Table 2.
Comparison of patients’ laboratory findings.
| Group | NHM(n = 556) | HM(n = 134) | P value |
|---|---|---|---|
| α1-MG [mg/L, M (P25, P75)] | 5.30 (3.32, 8.64) ** | 11.10 (5.69, 20.44) | < 0.01 |
| mAlb [mg/L, M (P25, P75)] | 11.28 (7.81, 16.10) ** | 35.50 (21.47, 73.24) | < 0.01 |
| HCY (μmol/L) | 14.72 ± 7.73 * | 16.81 ± 9.42 | 0.02 |
| ALT [U/L, M (P25, P75)] | 17.30 (12.7, 25.3) | 16.80 (11.45, 26.5) | 0.39 |
| AST [U/L, M (P25, P75)] | 19.30 (16.3, 24.2) | 19.50 (15.8, 28.45) | 0.36 |
| BUN (mg/dL) | 31.02 ± 10.2** | 34.32 ± 14.34 | < 0.01 |
| UA (mg/dL) | 5.38 ± 1.37** | 5.53 ± 1.77 | < 0.01 |
| Scr [mg/dL, M (P25, P75)] | 0.76 (0.64, 0.88) ** | 0.82 (0.64, 1.02) | < 0.01 |
| TG (mg/dL) | 131.12 ± 89.76 | 138.16 ± 88.00 | 0.36 |
| RBP (mg/dL) | 5.04 ± 1.25** | 5.35 ± 1.65 | < 0.01 |
| LDL-c (mg/dL) | 101.68 ± 31.70 | 92.26 ± 30.93 | 0.48 |
| HDL-c (mg/dL) | 44.46 ± 10.44 | 43.30 ± 10.05 | 0.50 |
| TC (mg/dL) | 170.92 ± 40.99 | 165.89 ± 42.54 | 0.56 |
| eGFR (ml/min) | 108.55 ± 24.71** | 98.08 ± 38.92 | < 0.01 |
| SOD (U/mL) | 168.31 ± 18.16** | 163.53 ± 22.41 | < 0.01 |
| Lpa [mg/dL, M (P25, P75)] | 13.03 (6.70, 25.81) | 13.91 (6.95, 25.14) | 0.83 |
| GLU (mg/dL) | 94.42 ± 14.76 * | 97.2 ± 17.64 | 0.04 |
The data are presented as mean ± SD for continuous variables and M (P25, P75) for incontinuous variables, n for categorical variables.
α1-MG ɑ1-microglobin, mAlb Urinary microalbumin, Hcy Homocysteine, ALT Alanine aminotransferase, AST Aspartate aminotransferase, BUN Blood urea, UA Blood uric acid, Scr Serum creatinine, TG Triglycerides, RBP Retinol-binding protein, LDL-c Low density lipoprotein-cholesterol, HDL-c High-density lipoprotein cholesterol, TC Total cholesterol, Egfr Estimation of the glomerular filtration rate, SOD Superoxide dismutase, Lpa lipoprotein A, GLU Blood glucose.
*significantly different from the HM group (P < 0.05)
**significantly different from the HM group (P < 0.01).